Metropolitan Life Insurance Company (MetLife)’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $68.2K | Hold |
|
|||||
|
2023
Q4 | $74.1K | Hold |
|
|||||
|
2023
Q3 | $35.8K | Buy |
|
|||||
|
2023
Q2 | $47K | Hold |
|
|||||
|
2023
Q1 | $34.2K | Sell |
|
|||||
|
2022
Q4 | $51.3K | Hold |
|
|||||
|
2022
Q3 | $37.4K | Hold |
|
|||||
|
2022
Q2 | $23.6K | Hold |
|
|||||
|
2022
Q1 | $46.4K | Sell |
|
|||||
|
2021
Q4 | $340K | Sell |
|
|||||
|
2021
Q3 | $294K | Hold |
|
|||||
|
2021
Q2 | $243K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $91.3K | Buy |
|